WMT
58
2
IRM
65
-8
JCI
47
-2
ADSK
61
-2
LNC
69
4
KHC
24
-3
D
40
3
IR
54
-3
ADT
48
-3
MSFT
46
-11
PDCO
38
-2
NTRS
50
-5
K
59
6
URBN
44
-2
CME
56
-2
CCL
82
-2
PVH
55
-3
BRK.B
36
-2
RRC
39
-11
GOOG
59
-10
WMT
58
2
IRM
65
-8
JCI
47
-2
ADSK
61
-2
LNC
69
4
KHC
24
-3
D
40
3
IR
54
-3
ADT
48
-3
MSFT
46
-11
PDCO
38
-2
NTRS
50
-5
K
59
6
URBN
44
-2
CME
56
-2
CCL
82
-2
PVH
55
-3
BRK.B
36
-2
RRC
39
-11
GOOG
59
-10
Financhill
Back

Nuveen S&P 500 Buy-Write Income Fund Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
37

BXMX
Nuveen S&P 500 Buy-Write Income Fund

Last Price:
13.68
Seasonality Move:
-0.36%
Buy
71

MDGL
Madrigal Pharmaceuticals

Last Price:
298.41
Seasonality Move:
31.67%
Sell
37
Nuveen S&P 500 Buy-Write Income Fund (BXMX) is a Sell

Is Nuveen S&P 500 Buy-Write Income Fund a Buy, Sell or Hold?

  • The current Nuveen S&P 500 Buy-Write Income Fund [BXMX] share price is $13.59. The Score for BXMX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BXMX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BXMX Stock Price Chart

What is Nuveen S&P 500 Buy-Write Income Fund's stock price today?

  • The Nuveen S&P 500 Buy-Write Income Fund share price today is $13.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXMX is experiencing selling pressure, which indicates risk of future bearish movement.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $259.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

BXMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 44.61 Sell
Chaikin Money Flow: -127584 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.64 - 13.8) Sell
Bollinger Bands (100): (13.18 - 13.7) Buy

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 74.74 Buy
Chaikin Money Flow: 898979 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (203.29 - 223.91) Buy
Bollinger Bands (100): (221.8 - 277.54) Buy

BXMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.73 Sell
20-day SMA: 13.74 Sell
50-day SMA: 13.58 Buy
200-day SMA: 13.25 Buy
8-day EMA: 13.72 Sell
20-day EMA: 13.71 Sell
50-day EMA: 13.6 Sell
200-day EMA: 13.3 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 216.22 Buy
20-day SMA: 214.16 Buy
50-day SMA: 227.04 Buy
200-day SMA: 240.71 Buy
8-day EMA: 223.2 Buy
20-day EMA: 218.42 Buy
50-day EMA: 226.38 Buy
200-day EMA: 233.63 Buy

Nuveen S&P 500 Buy-Write Income Fund Earnings Growth & BXMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.

Nuveen S&P 500 Buy-Write Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):